English
Home > Products > CAS:175865-59-5

China CAS:175865-59-5 Manufacturer

The key to our success is "Good Products Good quality, Reasonable Price and Efficient Service" for CAS:175865-59-5, In order to expand our international market, we mainly supply our oversea customers Top quality performance products and service.
CAS:175865-59-5, We hope to have long-term cooperation relationships with our clients. If you are interested in any of our items, be sure to do not hesitate to send enquiry to us/company name. We ensure that you can be totally satisfied with our best solutions!

Related Products

Hot Products

  • Finasteride

    Finasteride

    Finasteride has EP, USP, CP, IP, JP specifications. CEP available, FDA, PMDA and GMP approved.

    CAS:98319-26-7

  • Testosterone Cypionate

    Testosterone Cypionate

    Testosterone Cypionate has USP specification. TP available and DMF under filing.

    CAS:58-20-8

  • Valganciclovir Hydrochloride

    Valganciclovir Hydrochloride

    Valganciclovir Hydrochloride has USP specification. DMF approved.

    CAS:175865-59-5

  • Revefenacin

    Revefenacin

    Revefenacin has In-house specification. DMF approved.

    CAS:864750-70-9

  • Compound Mifepristone Tablets

    Compound Mifepristone Tablets

    Compound Mifepristone Tablets Specifications：Mifepristone 30mg Anorethidrane 5mg*2
    Indications：Abortion
  • Estrone

    Estrone

    Estrone is a female sex hormone. The weakest type of estrogen, it’s typically higher after menopause. Like all estrogen, estrone supports female sexual development and function. Low or high estrone can cause symptoms such as irregular bleeding, fatigue or mood swings.

    CAS:53-16-7

  • Related Blog
  • Reviews

  • October 24-26, 2023 CPHI Worldwide Pharmaceutical Industry Professional Exhibition in Spain

    Gedian Humanwell is a modern high-tech pharmaceutical company specializing in the R&D, production and sales of fertility regulation drugs and steroidal APIs. Our team will be at API Hall, booth 81B40, welcome to visit us!

  • 2024 CPhI Exhibition Shanghai

    In 2024, CPhI China will continue to be a unique opportunity for global pharmaceutical companies, manufacturers and suppliers. We will be waiting for you at the W1G20 booth on time to explore and interpret new trends in the pharmaceutical industry and interact with each other to further expand their business cooperation and various business opportunities. See you in Shanghai!

  • What are the categories of pharmaceutical intermediates?

    Pharmaceutical intermediates are classified by therapeutic areas, chemical structures, synthesis stages and production technologies, covering multiple types such as anti-tumor and anti-infection. They are key precursors in the synthesis of active pharmaceutical ingredients.

  • Is This the Best Intermediate Course for Practical Project Experience

    Ever found yourself scrolling through endless course listings, wondering which one actually bridges the gap between theory and a tangible, portfolio-worthy project? I’ve been there. With two decades in the tech industry, I’ve seen countless learners in the Intermediates Category hit a frustrating plateau. They know the basics but struggle to apply them convincingly in real-world scenarios. This is the core pain point we aimed to solve.

  • Meet Us at CPHI Japan 2026 – Booth 2K32

    We will attend CPHI Japan 2026 at Tokyo Big Sight from April 21 to 23, with booth 2K32.

  • What Is Desonide and How Does This Mild Corticosteroid Support Effective Skin Treatment

    Humanwell provides high-quality pharmaceutical solutions, including Desonide, a mild topical corticosteroid widely used in dermatological care. As a trusted pharmaceutical ingredient supplier, Humanwell focuses on consistent quality, reliable production standards, and professional support for global customers seeking effective anti-inflammatory compounds.

Send Inquiry

Hit enter to search or ESC to close
X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept